Clinical trial
Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia…
NCT00388531 · PETHEMA Foundation, Other · Completed
Key facts
| NCT number | NCT00388531 |
|---|---|
| Title | Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma |
| Official title | Multicenter, Prospective, Open Label Trial, Uncontrolled to Determine the Efficacy and Safety of Depocyt ® for the Treatment of CNS Relapse in Adult Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma |
| Lead sponsor | PETHEMA Foundation, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoblastic Leukemia, Lymphoma |
| Intervention type | Drug |
| Interventions | Depocyte® |
| Enrollment | 10 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | Oct 17, 2006 |
| Last update posted | Sep 19, 2011 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: